相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Hepatitis C Infection in the Elderly
Sammy Saab et al.
DIGESTIVE DISEASES AND SCIENCES (2015)
Ledipasvir and Sofosbuvir Plus Ribavirin for Treatment of HCV Infection in Patients With Advanced Liver Disease
Michael Charlton et al.
GASTROENTEROLOGY (2015)
Ledipasvir and sofosbuvir in patients with genotype 1 hepatitis C virus infection and compensated cirrhosis: An integrated safety and efficacy analysis
K. Rajender Reddy et al.
HEPATOLOGY (2015)
Improvement of health-related quality of life and work productivity in chronic hepatitis C patients with early and advanced fibrosis treated with ledipasvir and sofosbuvir
Zobair M. Younossi et al.
JOURNAL OF HEPATOLOGY (2015)
Ledipasvir-sofosbuvir with or without ribavirin to treat patients with HCV genotype 1 infection and cirrhosis non-responsive to previous protease-inhibitor therapy: a randomised, double-blind, phase 2 trial (SIRIUS)
Marc Bourliere et al.
LANCET INFECTIOUS DISEASES (2015)
Ledipasvir and sofosbuvir fixed-dose combination with and without ribavirin for 12 weeks in treatment-naive and previously treated Japanese patients with genotype 1 hepatitis C: an open-label, randomised, phase 3 trial
Masashi Mizokami et al.
LANCET INFECTIOUS DISEASES (2015)
Ledipasvir and Sofosbuvir for HCV in Patients Coinfected with HIV-1
Susanna Naggie et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
The impact of hepatitis C burden: an evidence-based approach
Z. M. Younossi et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2014)
Chronic Hepatitis C Virus Infection in the United States, National Health and Nutrition Examination Survey 2003 to 2010
Maxine M. Denniston et al.
ANNALS OF INTERNAL MEDICINE (2014)
The changing epidemiology of hepatitis C virus infection in the United States: National health and nutrition examination survey 2001 through 2010
Ivo Ditah et al.
JOURNAL OF HEPATOLOGY (2014)
Ledipasvir and Sofosbuvir for Untreated HCV Genotype 1 Infection
Nezam Afdhal et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Ledipasvir and Sofosbuvir for Previously Treated HCV Genotype 1 Infection
Nezam Afdhal et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Ledipasvir and Sofosbuvir for 8 or 12 Weeks for Chronic HCV without Cirrhosis
Kris V. Kowdley et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Age-related differences in response to peginterferon alfa-2a/ribavirin in patients with chronic hepatitis C infection
Claudia Roeder et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2014)
Hepatitis C Virus Testing of Persons Born During 1945-1965: Recommendations From the Centers for Disease Control and Prevention
Bryce D. Smith et al.
ANNALS OF INTERNAL MEDICINE (2012)
Global Burden of Hepatitis C: Considerations for Healthcare Providers in the United States
Francisco M. Averhoff et al.
CLINICAL INFECTIOUS DISEASES (2012)
Association Between Sustained Virological Response and All-Cause Mortality Among Patients With Chronic Hepatitis C and Advanced Hepatic Fibrosis
Adriaan J. van der Meer et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2012)
Projected future increase in aging hepatitis C virus-infected liver transplant candidates: A potential effect of hepatocellular carcinoma
Scott W. Biggins et al.
LIVER TRANSPLANTATION (2012)
Antiviral Therapy Reduces Risk of Hepatocellular Carcinoma in Patients With Hepatitis C Virus-Related Cirrhosis
Ashwani K. Singal et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2010)
Aging of Hepatitis C Virus (HCV)-Infected Persons in the United States: A Multiple Cohort Model of HCV Prevalence and Disease Progression
Gary L. Davis et al.
GASTROENTEROLOGY (2010)
Changing Trends in Hepatitis C Infection over the Past 50 Years in Japan
Hobyung Chung et al.
INTERVIROLOGY (2010)
Efficacy of peginterferon-α-2b plus ribavirin in patients aged 65 years and older with chronic hepatitis C
Takashi Honda et al.
LIVER INTERNATIONAL (2010)
Age and Prediction of Sustained Virological Response to Hepatitis C Virus (HCV) Infection Treatment Based on 28-Day Decrease in HCV RNA Levels
Giorgio Antonucci et al.
JOURNAL OF INFECTIOUS DISEASES (2009)
Anemia in liver transplant recipients undergoing antiviral treatment for recurrent hepatitis C
Sammy Saab et al.
LIVER TRANSPLANTATION (2007)
Sustained virological response to interferon-alpha is associated with improved outcome in HCV-related cirrhosis: A retrospective study
Savino Bruno et al.
HEPATOLOGY (2007)
Transmission of hepatitis C virus by blood transfusions and other medical procedures: A global review
Daniele Prati
JOURNAL OF HEPATOLOGY (2006)
The contributions of hepatitis B virus and hepatitis C virus infections to cirrhosis and primary liver cancer worldwide
Joseph F. Perz et al.
JOURNAL OF HEPATOLOGY (2006)
Hepatitis C in 6,865 patients 65 yr or older: A severe and neglected curable disease?
Dominique Thabut et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2006)
Elderly patients are at greater risk of cytopenia during antiviral therapy for hepatitis C
C. G. Nudo et al.
CANADIAN JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2006)
Factors contributing to ribavirin dose reduction due to anemia during interferon alfa2b and ribavirin combination therapy for chronic hepatitis C
S Takaki et al.
JOURNAL OF GASTROENTEROLOGY (2004)
Global burden of disease (GBD) for hepatitis C
Y Hutin et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2004)
Factors contributing to ribavirin-induced anemia
H Nomura et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2004)
Projecting future complications of chronic hepatitis C in the United States
GL Davis et al.
LIVER TRANSPLANTATION (2003)
分享论文
